Table 5.
bBSI (n = 65) n/N (%) |
bGII (n = 65) n/N (%) |
pGII (n = 215) n/N (%) |
vGII (n = 29) n/N (%) |
UTI (n = 11) n/N (%) |
CBPN (n = 153) n/N (%) |
No infectiona (n = 269) n/N (%) |
|
---|---|---|---|---|---|---|---|
Referral hospital | 40/65 (61.54%) | 14/65 (21.54) | 40/215 (18.60) | 6/29 (20.69) | 3/11 (27.27) | 41/153 (26.80) | 86/269 (31.97) |
Antimalarial | 31/40 (77.5) | 8/14 (57.14) | 29/40 (72.5) | 3/6 (50) | 3/3 (100) | 21/41 (51.21) | 30/86 (34.88) |
Antibiotic | 30/40 (75) | 9/14 (64.28) | 29/40 (72.5) | 6/6 (100) | 3/3 (100) | 33/41 (80.48) | 74/86 (86.04) |
Antiparasitic | 0/40 (0) | 0/14 (0) | 1/40 (2.50) | 1/6 (16.67) | 0/3 (0) | 1/41 (2.43) | 2/86 (2.32) |
Health facilities | 25/65 (38.46) | 51/56 (78.46) | 175/215 (81.40) | 23/29 (79.31) | 8/11 (72.73) | 112/153 (73.20) | 183/269 (68.02) |
Antimalarial | 16/25 (64) | 39/51 (76.47) | 129/175 (73.71) | 13/23 (56.52) | 7/8 (87.5) | 85/112 (75.89) | 86/183 (46.99) |
Antibiotic | 25/25 (100) | 41/51 (80.39) | 141/175 (80.57) | 20/23 (86.95) | 8/8 (100) | 97/112 (86.60) | 172/183 (93.98) |
Antiparasitic | 5/25 (20.00) | 16/51 (31.37) | 30/175 (17.14) | 4/23 (17.39) | 1/8 (12.5) | 20/112 (17.85) | 47/183 (25.68) |
bBSI bacterial bloodstream infection, bGII bacterial gastro-intestinal infection, vGII viral gastro-intestinal infection, UTI urinary tract infection, CBPN common bacteria pathogens of nasopharynx
aIncluding malaria infection